Related Experiment Video
Updated: Jun 17, 2025

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
Published on: August 11, 2017
Is It Working? Evaluating The First Round Of Medicare Drug Price Negotiations
1Laura Tollen (ltollen@projecthope.org) is a senior editor at Health Affairs, in Washington, D.C. This article is informed by the deliberations of the Health Affairs IRA Observatory. Opinions expressed are those of the author and do not necessarily reflect those of the Observatory members or their employers. The Health Affairs IRA Observatory and the Eye On The IRA article series are supported by the National Pharmaceutical Council. [Published online August 13, 2024.].
Abstract:
In the short and longer terms, the Medicare Drug Price Negotiation Program should be evaluated based on four categories of outcomes: beneficiary access, prices and spending, promotion of value, and effects on innovation.
Related Concept Videos
Drug Regulation
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Drug Control Governance: Regulatory Bodies and Their Impact
Factors Influencing Drug Absorption: Presystemic Elimination

